Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin in Moderate Volume Paracentesis for Decompensated Cirrhosis
NCT02467322Completed
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Feb 2015
- Primary completion
- Dec 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of albumin (human) in decompensated cirrhosis (2 arms), sponsored by Institute of Liver and Biliary Sciences. Primary endpoint: Incidence of Paracentesis Induced Circulatory Dysfunction at 1 year. Started Feb 2015; status: completed.
02
Drugs
albumin (human)
03
Conditions
decompensated cirrhosis
Beyond the preview
Go deeper on NCT02467322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02467322.